Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01231165Phase 3Completed
A Phase 3 trial of amiloride in coronary heart disease (CHD), sponsored by Universidad de Carabobo. Started Feb 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01231165.